Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China

详细信息    查看全文

• 作者：Weixia Ke ; Chi Zhang ; Li Liu ; Yanhui Gao ; Zhenjiang Yao…
• 关键词：Cost ; effectiveness ; Chronic hepatitis B ; Tenofovir disoproxil fumarate
• 刊名：Hepatology International
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：10
• 期：6
• 页码：924-936
• 全文大小：1,037 KB
• 刊物主题：Hepatology; Colorectal Surgery; Surgery;
• 出版者：Springer India
• ISSN：1936-0541
• 卷排序：10

文摘

BackgroundTenofovir disoproxil fumarate (TDF) is newly available for treatment of chronic hepatitis B patients in China. To date, no study has been conducted to examine the cost-effectiveness of this treatment. The aim of this study was to estimate the cost-effectiveness of TDF versus four oral nucleos(t)ide analogs [lamivudine (LAM), adefovir (ADV), telbivudine (LdT), and entecavir (ETV)] and from a pharmacoeconomic perspective to assess current drug pricing for TDF.